Stephen Andrew Snyder, President at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), bought 5,000 shares at $1.33 ($7K) on 2015-11-30, disclosed to the SEC on 2015-12-01.
Open-market purchase of $7k MTBC by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MTBC | SELL | 2022-10-20 | $214K | — | Filing → |
| MTBC | SELL | 2022-10-07 | $40K | — | Filing → |
| MTBC | SELL | 2022-10-05 | $37K | — | Filing → |